Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
J Urol. 2012 Dec;188(6):2288-93. doi: 10.1016/j.juro.2012.07.104. Epub 2012 Oct 22.
We recently reported an association between the bother and severity of lower urinary tract symptoms secondary to benign prostatic hyperplasia and the severity of sleep disturbance. However, few studies have examined whether alterations in the severity of urinary symptoms influence the degree of sleep problems over time.
The severity of lower urinary tract symptoms in men enrolled in CAMUS (Complementary and Alternative Medicine for Urological Symptoms), a clinical trial of saw palmetto (Serenoa repens), was evaluated using AUASI (American Urological Association symptom index) and quality of life scores. Sleep disturbance was evaluated by the Jenkins sleep scale at 0, 24, 48 and 72 weeks. Statistical analyses were used to assess the relationship(s) between changes in lower urinary tract symptoms and sleep disturbance.
The baseline characteristics of the 339 men (172 placebo arm and 167 saw palmetto arm) enrolled in the CAMUS trial with assessment of sleep disturbance and urinary symptoms were similar. There were no differences between improvements in the severity of sleep disturbance or urinary symptoms between the 2 experimental arms. Combined analyses of the entire cohort revealed significant associations (p <0.001) between the AUASI score and sleep disturbance severity with time. Multivariate analyses demonstrated that improvements in lower urinary tract symptoms other than nocturia were the most significant predictors of improvements in sleep disturbance. Specific analyses adjusting for other baseline characteristics demonstrated that a 3-point improvement in AUASI score was associated with a 0.73-point improvement in the Jenkins sleep scale with time.
Improvements in lower urinary tract symptoms correlate with changes in sleeping abilities with time in men with benign prostatic hyperplasia. While nocturia is significantly associated with sleep disturbance, other changes in overall lower urinary tract symptoms are better predictors of changes in sleep dysfunction.
我们最近报道了良性前列腺增生症(BPH)下尿路症状(LUTS)的困扰和严重程度与睡眠障碍严重程度之间的关系。然而,很少有研究探讨尿症状严重程度的变化是否会影响随时间推移睡眠问题的严重程度。
CAMUS(前列腺症状的补充和替代医学)临床试验中,使用 AUASI(美国泌尿协会症状指数)和生活质量评分评估入组男性的下尿路症状严重程度。在 0、24、48 和 72 周时,使用詹金斯睡眠量表评估睡眠障碍。统计分析用于评估下尿路症状和睡眠障碍变化之间的关系。
CAMUS 试验中评估睡眠障碍和尿症状的 339 名男性(172 名安慰剂组和 167 名锯棕榈组)的基线特征相似。2 个实验组之间在睡眠障碍或尿症状严重程度改善方面没有差异。整个队列的综合分析显示 AUASI 评分与睡眠障碍严重程度与时间之间存在显著关联(p <0.001)。多变量分析表明,除夜尿症以外的下尿路症状改善是睡眠障碍改善的最显著预测因素。在调整其他基线特征的特定分析中,AUASI 评分改善 3 分与詹金斯睡眠量表评分随时间改善 0.73 分相关。
在患有 BPH 的男性中,下尿路症状的改善与随时间推移睡眠能力的变化相关。虽然夜尿症与睡眠障碍显著相关,但整体下尿路症状的其他变化是睡眠功能障碍变化的更好预测因素。